Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype.

Tadros, Audree B; Sevilimedu, Varadan; Giri, Dilip D; Zabor, Emily C; Morrow, Monica; Plitas, George

Tadros, Audree B; Sevilimedu, Varadan; Giri, Dilip D; Zabor, Emily C; Morrow, Monica; Plitas, George.

Afiliación

Tadros AB; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sevilimedu V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Giri DD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Zabor EC; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Morrow M; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Plitas G; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ann Surg Oncol ; 28(8): 4245-4253, 2021 Aug.

Article en En | MEDLINE | ID: mdl-33389291

Asunto(s)

Neoplasias de la Mama; Neoplasias de la Mama Triple Negativas; Mama; Neoplasias de la Mama/terapia; Femenino; Humanos; Metaplasia; Terapia Neoadyuvante; Recurrencia Local de Neoplasia; Neoplasias de la Mama Triple Negativas/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Límite: Female / Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google